Company Search:
Advanced Search
Sponsored Links
Biocryst Pharmaceuticals Inc Company Snapshot
Biocryst Pharmaceuticals Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biocryst Pharmaceuticals Inc with three other companies in this sector in the United States: Teligent Inc (2015 sales of $44.25 million of which 100% was Cosmetic Products), Vericel Corp ($51.17 million of which 100% was Autologous Cell Products), and Sangamo Therapeutics Inc ($39.54 million of which 100% was Research & Colloboration).

Sales Analysis. Sales increased substantially in 2015: Biocryst Pharmaceuticals Inc reported sales of $48.26 million for the year ending December of 2015. This represents an increase of 254.6% versus 2014, when the company's sales were $13.61 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biocryst Pharmaceuticals Inc
  Stock Performance Chart for Biocryst Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 6.56
(Figures in U.S. Dollars)
1 Week 15.9%   13 Weeks 10.3%  
4 Weeks 9.7%   52 Weeks 218.4%  
Biocryst Pharmaceuticals Inc Key Data:
  Ticker: BCRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 48,257,000
(Year Ending Jan 2016).
Employees: 70
  Currency: U.S. Dollars Market Cap: 483,854,579
  Fiscal Yr Ends: December Shares Outstanding: 73,758,320
  Share Type: Common Closely Held Shares: 1,056,521
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.